BACKGROUND: Type 2 diabetes mellitus increases the risk of cognitive decline and dementia, and elevated burdens of vascular disease are hypothesized to contribute to this risk. These relationships were examined in the Diabetes Heart Study-MIND using a battery of cognitive tests, neuroimaging measures and subclinical cardiovascular disease (CVD) burden assessed by coronary artery calcified (CAC) plaque. We hypothesized that CAC would attenuate the association between neuroimaging measures and cognition performance. METHODS: Associations were examined using marginal models in this family-based cohort of 572 European Americans from 263 families. All models were adjusted for age, gender, education, type 2 diabetes and hypertension, with some neuroimaging measures additionally adjusted for intracranial volume. RESULTS: Higher total brain volume was associated with better performance on the Digit Symbol Substitution Task and Semantic Fluency (both p ≤ 7.0 × 10(-4)). Higher gray matter volume was associated with better performance on the Modified Mini-Mental State Examination and Semantic Fluency (both p ≤ 9.0 × 10(-4)). Adjusting for CAC caused minimal changes to the results. CONCLUSIONS: Relationships exist between neuroimaging measures and cognitive performance in a type 2 diabetes-enriched European American cohort. Associations were minimally attenuated after adjusting for subclinical CVD. Additional work is needed to understand how subclinical CVD burden interacts with other factors and impacts relationships between neuroimaging and cognitive testing measures.
BACKGROUND:Type 2 diabetes mellitus increases the risk of cognitive decline and dementia, and elevated burdens of vascular disease are hypothesized to contribute to this risk. These relationships were examined in the Diabetes Heart Study-MIND using a battery of cognitive tests, neuroimaging measures and subclinical cardiovascular disease (CVD) burden assessed by coronary artery calcified (CAC) plaque. We hypothesized that CAC would attenuate the association between neuroimaging measures and cognition performance. METHODS: Associations were examined using marginal models in this family-based cohort of 572 European Americans from 263 families. All models were adjusted for age, gender, education, type 2 diabetes and hypertension, with some neuroimaging measures additionally adjusted for intracranial volume. RESULTS: Higher total brain volume was associated with better performance on the Digit Symbol Substitution Task and Semantic Fluency (both p ≤ 7.0 × 10(-4)). Higher gray matter volume was associated with better performance on the Modified Mini-Mental State Examination and Semantic Fluency (both p ≤ 9.0 × 10(-4)). Adjusting for CAC caused minimal changes to the results. CONCLUSIONS: Relationships exist between neuroimaging measures and cognitive performance in a type 2 diabetes-enriched European American cohort. Associations were minimally attenuated after adjusting for subclinical CVD. Additional work is needed to understand how subclinical CVD burden interacts with other factors and impacts relationships between neuroimaging and cognitive testing measures.
Authors: Lenore J Launer; Michael E Miller; Jeff D Williamson; Ron M Lazar; Hertzel C Gerstein; Anne M Murray; Mark Sullivan; Karen R Horowitz; Jingzhong Ding; Santica Marcovina; Laura C Lovato; James Lovato; Karen L Margolis; Patrick O'Connor; Edward W Lipkin; Joy Hirsch; Laura Coker; Joseph Maldjian; Jeffrey L Sunshine; Charles Truwit; Christos Davatzikos; R Nick Bryan Journal: Lancet Neurol Date: 2011-09-28 Impact factor: 44.182
Authors: A Verdelho; S Madureira; C Moleiro; J M Ferro; C O Santos; T Erkinjuntti; L Pantoni; F Fazekas; M Visser; G Waldemar; A Wallin; M Hennerici; D Inzitari Journal: Neurology Date: 2010-07-13 Impact factor: 9.910
Authors: Tamar S Polonsky; Robyn L McClelland; Neal W Jorgensen; Diane E Bild; Gregory L Burke; Alan D Guerci; Philip Greenland Journal: JAMA Date: 2010-04-28 Impact factor: 56.272
Authors: Yael D Reijmer; Esther van den Berg; Jeroen de Bresser; Roy P C Kessels; L Jaap Kappelle; Ale Algra; Geert Jan Biessels Journal: Diabetes Metab Res Rev Date: 2011-02 Impact factor: 4.876
Authors: Donald W Bowden; Amanda J Cox; Barry I Freedman; Christina E Hugenschimdt; Lynne E Wagenknecht; David Herrington; Subhashish Agarwal; Thomas C Register; Joseph A Maldjian; Maggie C-Y Ng; Fang-Chi Hsu; Carl D Langefeld; Jeff D Williamson; J Jeffrey Carr Journal: Rev Diabet Stud Date: 2010-11-10
Authors: Suzette E Elias-Smale; Rozemarijn Vliegenthart Proença; Michael T Koller; Maryam Kavousi; Frank J A van Rooij; Myriam G Hunink; Ewout W Steyerberg; Albert Hofman; Matthijs Oudkerk; Jacqueline C M Witteman Journal: J Am Coll Cardiol Date: 2010-10-19 Impact factor: 24.094
Authors: Yael D Reijmer; Esther van den Berg; Carla Ruis; L Jaap Kappelle; Geert Jan Biessels Journal: Diabetes Metab Res Rev Date: 2010-10 Impact factor: 4.876
Authors: J Richard Jennings; Israel C Christie; Matthew F Muldoon; Christopher M Ryan; Julie C Price; Carolyn C Meltzer Journal: Psychosom Med Date: 2010-07-16 Impact factor: 4.312
Authors: Majon Muller; Auke P A Appelman; Yolanda van der Graaf; Koen L Vincken; Willem P Th M Mali; Mirjam I Geerlings Journal: Neurobiol Aging Date: 2009-06-10 Impact factor: 4.673
Authors: Fang-Chi Hsu; Mingxia Yuan; Donald W Bowden; Jianzhao Xu; S Carrie Smith; Lynne E Wagenknecht; Carl D Langefeld; Jasmin Divers; Thomas C Register; J Jeffrey Carr; Jeff D Williamson; Kaycee M Sink; Joseph A Maldjian; Barry I Freedman Journal: J Diabetes Complications Date: 2016-08-19 Impact factor: 2.852
Authors: Laura M Raffield; Amanda J Cox; Barry I Freedman; Christina E Hugenschmidt; Fang-Chi Hsu; Benjamin C Wagner; Jianzhao Xu; Joseph A Maldjian; Donald W Bowden Journal: Acta Diabetol Date: 2015-11-02 Impact factor: 4.280
Authors: Timothy M Hughes; Kaycee M Sink; Jeff D Williamson; Christina E Hugenschmidt; Benjamin C Wagner; Christopher T Whitlow; Jianzhao Xu; S Carrie Smith; Lenore J Launer; Joshua I Barzilay; Faramarz Ismail-Beigi; R Nick Bryan; Fang-Chi Hsu; Donald W Bowden; Joseph A Maldjian; Jasmin Divers; Barry I Freedman Journal: J Diabetes Complications Date: 2018-05-29 Impact factor: 2.852